EN
CN

Investor Relations

Create Sustainable Growth Value for Investors

Announcements & Circulars
  • NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
    02-03-2026
  • NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
    02-02-2026
  • MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026
    02-02-2026
  • NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
    01-30-2026
  • NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
    01-29-2026
  • NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK
    01-28-2026
Financial Reports
  • Default image
    Interim Report 2025
  • Default image
    Annual Report 2024
  • Default image
    Interim Report 2024
  • Default image
    Annual Report 2023
Corporate Governance
  • Articles of Association
  • Procedures for Nomination of Directors
  • SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED ANTI-CORRUPTION POLICY
  • SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED WHISTLE-BLOWING AND INVESTIGATION POLICY
Investor presentation materials
BRIEFING ON THE TRANSACTION WITH WEIGAO BLOOD PURIFICATION 0106
  • Weigao Group:Interim Result 2025
  • Weigao Group: Annual Result of 2024
  • Weigao Group:Interim Result of 2024
Investor Contact

ir@weigaogroup.com

1 Weigao Road,Torch Hight-Tech Industrial Development Zone, Weihai, Shandong Province, China